Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn’s disease

Nichols, B. et al. (2024) Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn’s disease. American Journal of Clinical Nutrition, 119(4), pp. 885-895. (doi: 10.1016/j.ajcnut.2023.12.027) (PMID:38569785) (PMCID:PMC11007740)

[img] Text
315817_Suppl_Tables.pdf - Supplemental Material

235kB
[img] Text
315817_Suppl_Figures.pdf - Supplemental Material

655kB
[img] Text
315817_Suppl_Methods.pdf - Supplemental Material

152kB
[img] Text
315817.pdf - Published Version
Available under License Creative Commons Attribution.

508kB

Abstract

Background: Predicting response to exclusive enteral nutrition (EEN) in active Crohn’s disease (CD) could lead to therapy personalization and pretreatment optimization. Objectives: This study aimed to explore the ability of pretreatment parameters to predict fecal calprotectin (FCal) levels at EEN completion in a prospective study in children with CD. Methods: In children with active CD, clinical parameters, dietary intake, cytokines, inflammation-related blood proteomics, and diet-related metabolites, metabolomics and microbiota in feces, were measured before initiation of 8 wk of EEN. Prediction of FCal levels at EEN completion was performed using machine learning. Data are presented with medians (IQR). Results: Of 37 patients recruited, 15 responded (FCal < 250 μg/g) to EEN (responders) and 22 did not (nonresponders). Clinical and immunological parameters were not associated with response to EEN. Responders had lesser (μmol/g) butyrate [responders: 13.2 (8.63–18.4) compared with nonresponders: 22.3 (12.0–32.0); P = 0.03], acetate [responders: 49.9 (46.4–68.4) compared with nonresponders: 70.4 (57.0–95.5); P = 0.027], phenylacetate [responders: 0.175 (0.013–0.611) compared with nonresponders: 0.943 (0.438–1.35); P = 0.021], and a higher microbiota richness [315 (269–347) compared with nonresponders: 243 (205–297); P = 0.015] in feces than nonresponders. Responders consumed (portions/1000 kcal/d) more confectionery products [responders: 0.55 (0.38–0.72) compared with nonresponders: 0.19 (0.01–0.38); P = 0.045]. A multicomponent model using fecal parameters, dietary data, and clinical and immunological parameters predicted response to EEN with 78% accuracy (sensitivity: 80%; specificity: 77%; positive predictive value: 71%; negative predictive value: 85%). Higher taxon abundance from Ruminococcaceae, Lachnospiraceae, and Bacteroides and phenylacetate, butyrate, and acetate were the most influential variables in predicting lack of response to EEN. Conclusions: We identify microbial signals and diet-related metabolites in feces, which could comprise targets for pretreatment optimization and personalized nutritional therapy in pediatric CD.

Item Type:Articles
Additional Information:This research received funding from The Glasgow Children’s Hospital Charity, Nestle Health Science and The Leona M. and Harry B. Helmsley Charitable Trust. ML received a studentship by the Engineering and Physical Sciences Research Council (EPSRC) and Nestle Health Science. UZI was funded by Natural Environment Research Council (NERC NE/L011956/1) and supported by EPSRC (EP/P029329/1 and EP/V030515/1). BN was partially funded by the Biotechnology and Biological Sciences Research Council (BB/R006539/1).
Keywords:Exclusive enteral nutrition, Crohn’s disease, microbiome, precision therapy, metabolome, short chain fatty acids, o'link, cytokines.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Hansen, Dr Richard and Russell, Dr Richard and Logan, Dr Michael and Havlik, Dr Jaroslav and Svolos, Dr Vaios and Gkikas, Dr Konstantinos and Nichols, Mr Ben and Milling, Professor Simon and Quince, Dr Christopher and Gerasimidis, Professor Konstantinos and BRIOLA, Ms ANNA and Ijaz, Dr Umer
Authors: Nichols, B., Briola, A., Logan, M., Havlik, J., Mascellani, A., Gkikas, K., Milling, S., Ijaz, U. Z., Quince, C., Svolos, V., Russell, R. K., Hansen, R., and Gerasimidis, K.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
College of Science and Engineering > School of Engineering
College of Science and Engineering > School of Engineering > Infrastructure and Environment
Research Centre:College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology
Journal Name:American Journal of Clinical Nutrition
Publisher:Elsevier
ISSN:0002-9165
ISSN (Online):1938-3207
Published Online:19 February 2024
Copyright Holders:Copyright © 2024 The Authors
First Published:First published in American Journal of Clinical Nutrition 119(4):885-895
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
170256Understanding microbial community through in situ environmental 'omic data synthesisUmer Zeeshan IjazNatural Environment Research Council (NERC)NE/L011956/1ENG - Infrastructure & Environment
300451Optimising decentralised low-cost wastewater infrastructure by managing the microbesWilliam SloanEngineering and Physical Sciences Research Council (EPSRC)EP/P029329/1ENG - Infrastructure & Environment
309846Decentralised water technologiesWilliam SloanEngineering and Physical Sciences Research Council (EPSRC)EP/V030515/1ENG - Infrastructure & Environment
300280The Role of Dietary D-serine in Health and DiseaseAndrew RoeBiotechnology and Biological Sciences Research Council (BBSRC)BB/R006539/1SII - Bacteriology